- 1、本文档共11页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Prostaglandin E1 treatment in patients with end-stage chronic renal failure Clinical
PAGE \* MERGEFORMAT 11
Prostaglandin E1 treatment in patients with end-stage chronic renal failure Clinical
Of: Ji-ren Zhang Zhong Jing-Hua Wang Yong Xiang Wu Rui-Lin Liu Yuan Shenping
[Abstract] Objective To evaluate the application of prostaglandin E1 (PGE1) treatment of end-stage chronic renal failure (ESRF) of clinical efficacy. Methods 22 patients with end-stage chronic renal failure (ESRF) in elderly patients into two groups, the control group 10 cases, according to Conventional disease medication to control blood pressure, correction of anemia, acidosis, electrolyte disorders. experimental group of 12 patients without the use of group based on the use PGE1 200 g in 10% glucose solution 500 ml intravenously, 1 / d, 3 courses of treatment were followed up for 3 months were observed in the clinical symptoms, laboratory tests, mortality and other related indicators. Results The edema, backache, fatigue, urine output, loss of appetite, skin itching and other symptoms than the control group improvement obvious. experimental urea nitrogen (BUN), creatinine (Scr), endogenous creatinine clearance rate (Ccr), urinary protein control group, the difference was significant (P lt;0.05). 25% mortality in the experimental group, 50% of the control group mortality difference between two groups were significantly (P lt;0.05). Conclusions PGE1 can slow down the process of chronic renal insufficiency, improving renal function and reduce mortality in end-stage chronic renal failure and improve prognosis.
[Keywords:] prostaglandin E1; end stage chronic renal failure
[Abstract] ObjectiveTo investigate the effect of prostaglandin-E1 (PGE1) on the treatment for end-stage renal failure (ESRF). Methods22 patients with ESRFwere chosen and divided into groups with and without PGE1 treatment. Patientsinboth groups were given basic treatment. PGE1 was added into group with PGE1 treatment. Patients of both groups were followed up for 3 months. Blood urea nitrogen (BUN), se
您可能关注的文档
- Progress in laparoscopic liver resection.doc
- Progress in invasion and metastasis of breast cancer.doc
- Progress in lithium salt Monitoring Methods.doc
- Progress in lipid-lowering medicine research.doc
- Progress in its separate analysis of traditional Chinese medicine.doc
- Progress in Mechanism of trichosanthin.doc
- Progress in medical therapy for esophageal cancer.doc
- Progress in lung cancer stem cell research.doc
- Progress in liver sinusoidal endothelial cells.doc
- Progress in medicine and earthworm.doc
最近下载
- TBIE 004—2023通孔回流焊接技术规范团标.pdf
- 国开《MySQL数据库应用》形考1-4(试题及答案).pdf VIP
- 煤矿安全生产作业规程操作规程安全技术措施编制审批贯彻及执行管理制度.doc
- 2020年光学膜行业研究报告.pdf
- 采血管种类和应用ppt课件.pptx VIP
- 职业生涯报告六篇.pdf VIP
- Unit 4 Plants arounds us PartA Let's talk(课件)人教PEP版(2024)英语三年级上册.pptx
- 七年级上册生物:必考问答式知识点汇总(背诵+默写).docx
- 《青纱帐——甘蔗林》课件【中职专用】高教版 基础模块下册.pptx
- 国家开放大学学位英语历年真题试卷号1909.docx
文档评论(0)